Who owns ZHENGYE BIOTECHNOLOGY HLDG L?
- Ticker: ZYBT
- CUSIP Number: g989ms101
Tip: Access positions for across all investors
Analyze quarterly positions in Zhengye Biotechnology Hldg L with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Zhengye Biotechnology Hldg L stock
Who bought or sold ZHENGYE BIOTECHNOLOGY HLDG L this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| XTX Topco | 59k | $68k | 71% | Dec 2025 |
|
| Winton Capital | 33k | $31k | -47% | Mar 2026 |
|
| Geode Capital Management | 29k | $27k | 0% | Mar 2026 |
|
| UBS Group | 8.0k | $7.5k | -12% | Mar 2026 |
|
| Tower Research Capital | 2.2k | $2.5k | -51% | Dec 2025 |
|
| Royal Bank of Canada | 1.2k | $999.990000 | 100% | Mar 2026 |
|
| Morgan Stanley | 261.00 | $244.165500 | -84% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 0% | Mar 2026 |
|
Who sold out of Zhengye Biotechnology Hldg L?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Invesco | Dec 2025 | 35k | $40k |
| Citadel Advisors | Dec 2025 | 31k | $35k |